4.7 Review

Features of Lipid Metabolism Disorders in Primary Biliary Cholangitis

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Alterations in gut microbiota and elevated serum bilirubin in primary biliary cholangitis patients treated with ursodeoxycholic acid

Weijia Han et al.

Summary: The study found that the TB level in PBC patients treated with UCDA for 12 months is associated with a distinct gut microbiome profile. Lower bacterial diversity was observed in patients with elevated TB levels, along with differential abundance of certain bacterial genera. The findings indicate a potential relationship between gut microbiota dysbiosis and TB levels in PBC patients.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2022)

Review Medicine, Research & Experimental

Pathogenesis and management of fatigue in primary biliary cholangitis

Dana Shamshtein et al.

Summary: Chronic fatigue is a common and bothersome symptom in PBC patients, but its pathogenesis and treatment outcomes are still not well understood. Biological, psychological, and social factors may contribute to the disease burden in fatigued PBC patients. Anti-inflammatory treatments show promise as a specific medical treatment option for relieving fatigue symptoms.

FATIGUE-BIOMEDICINE HEALTH AND BEHAVIOR (2022)

Review Biochemistry & Molecular Biology

The Role of Epigenetics in Primary Biliary Cholangitis

Alessio Gerussi et al.

Summary: This article discusses epigenetic modifications in Primary Biliary Cholangitis (PBC), including methylation, post-translational modifications of histone proteins, and non-coding RNA. The study found dysregulation of these modification levels, especially in immune cells, in PBC. The article also discusses the influence of X-chromosome abnormalities and abnormalities in X chromosome inactivation on the sex imbalance and pathogenesis of PBC.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Gastroenterology & Hepatology

Functional, Diagnostic and Therapeutic Aspects of Bile

Monjur Ahmed

Summary: Bile, a unique body fluid synthesized in the liver, plays a crucial role in various physiological functions. Bile acids, the most physiologically active component of bile, have multiple critical roles in our body. However, they can also be harmful in certain conditions.

CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY (2022)

Article Gastroenterology & Hepatology

The liver steatosis severity and lipid characteristics in primary biliary cholangitis

Yuan Zhang et al.

Summary: The study found that patients with primary biliary cholangitis (PBC) had lower degree of hepatic steatosis and higher levels of high-density lipoprotein cholesterol (HDL-C), which are protective factors against atherosclerosis and cardiovascular risk.

BMC GASTROENTEROLOGY (2021)

Review Gastroenterology & Hepatology

Current understanding of primary biliary cholangitis

Atsushi Tanaka

Summary: Primary biliary cholangitis (PBC) is an autoimmune disease that mainly affects middle-aged women but also young women and men. It is characterized by degeneration and necrosis of intrahepatic biliary epithelial cells, with early diagnosis through detection of antimitochondrial antibodies and introduction of ursodeoxycholic acid as first-line treatment significantly improving clinical outcomes.

CLINICAL AND MOLECULAR HEPATOLOGY (2021)

Review Nutrition & Dietetics

Malnutrition in Patients with Liver Cirrhosis

Julia Traub et al.

Summary: Liver cirrhosis is a growing public health threat globally, often accompanied by malnutrition. The underdiagnosis of malnutrition in cirrhosis patients underscores the importance of regular screening, assessment, and interventions by healthcare professionals. Further research is needed to better understand the pathogenic mechanisms and develop targeted therapeutic strategies for malnutrition in cirrhosis.

NUTRIENTS (2021)

Review Pathology

Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis

Samantha Sarcognato et al.

Summary: Autoimmune cholestatic liver diseases are rare hepato-biliary disorders characterized by progressive inflammatory destruction of bile ducts. Primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC) are the main diseases in this category, with liver transplantation being the only definitive treatment currently available.

PATHOLOGICA (2021)

Review Cardiac & Cardiovascular Systems

Lipoprotein-X fifty years after its original discovery

R. Fellin et al.

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2019)

Article Biochemistry & Molecular Biology

Lipid profiling of lipoprotein X: Implications for dyslipidemia in cholestasis

Susanne Heimerl et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2016)

Editorial Material Cell Biology

Of TICE in Men

David E. Cohen

Cell Metabolism (2016)

Article Gastroenterology & Hepatology

Fatigue in Primary Biliary Cirrhosis: Prevalence, Pathogenesis and Management

Laura Jopson et al.

DIGESTIVE DISEASES (2015)

Article Gastroenterology & Hepatology

Primary biliary cirrhosis: Clinical and laboratory criteria for its diagnosis

Vasiliy Ivanovich Reshetnyak

WORLD JOURNAL OF GASTROENTEROLOGY (2015)

Article Gastroenterology & Hepatology

Pathogenesis of Primary Biliary Cirrhosis and Its Fatigue

Laura Griffiths et al.

DIGESTIVE DISEASES (2014)

Editorial Material Medical Laboratory Technology

Lipoprotein X: clinical implications

M. A. Crook

ANNALS OF CLINICAL BIOCHEMISTRY (2013)

Review Biochemistry & Molecular Biology

Bile acid-activated receptors in the treatment of dyslipidemia and related disorders

Stefano Fiorucci et al.

PROGRESS IN LIPID RESEARCH (2010)

Review Gastroenterology & Hepatology

Primary Biliary Cirrhosis

Keith D. Lindor et al.

HEPATOLOGY (2009)

Article Public, Environmental & Occupational Health

Fatigue as a major predictor of quality of life in women with autoimmune liver disease - The case of primary biliary cirrhosis

Ellen D. Sogolow et al.

WOMENS HEALTH ISSUES (2008)

Review Cardiac & Cardiovascular Systems

Primary biliary cirrhosis, hyperlipidemia, and atherosclerotic risk: A systematic review

Alexey Sorokin et al.

ATHEROSCLEROSIS (2007)

Article Biochemistry & Molecular Biology

Lipoprotein-X reduces LDL atherogenicity in primary biliary cirrhosis by preventing LDL oxidation

PY Chang et al.

JOURNAL OF LIPID RESEARCH (2004)

Article Biochemistry & Molecular Biology

High density lipoprotein structure

S Lund-Katz et al.

FRONTIERS IN BIOSCIENCE-LANDMARK (2003)

Article Gastroenterology & Hepatology

Bezafibrate treatment: a new medical approach for PBC patients?

T Kanda et al.

JOURNAL OF GASTROENTEROLOGY (2003)